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Abstract
● AIM: To evaluate and compare the efficacy of the astigmatic 
correction achieved with laser in situ keratomileusis (LASIK) 
in eyes with myopic astigmatism using wavefront-guided 
(WFG) and wavefront-optimized (WFO) ablation profiles.
● METHODS: Prospective study included 221 eyes undergoing 
LASIK: 99 and 122 eyes with low and moderate myopic 
astigmatism (low and moderate myopia groups). Two 
subgroups were differentiated in each group according to 
the ablation profile: WFG subgroup, 109 eyes (45/64, low/
moderate myopia groups) treated using the Advanced 
CustomVue platform (Abbott Medical Optics Inc.), and 
WFO subgroup, 112 eyes (54/58, low/moderate myopia 
groups) treated using the EX-500 platform (Alcon). Clinical 
outcomes were evaluated during a 6-month follow-up, 
including a vector analysis of astigmatic changes.
● RESULTS: Significantly better postoperative uncorrected 
visual acuity and efficacy index was found in the WFG 
subgroups of each group (P≤0.041). Postoperative spherical 
equivalent and cylinder were significantly higher in WFO 
subgroups (P≤0.003). In moderate myopia group, a higher 
percentage of eyes with a postoperative cylinder ≤0.25 D 
was found in the WFG subgroup (90.6% vs 65.5%, P=0.002). 
In low and moderate myopia groups, the difference vector 
was significantly higher in the WFO subgroup compared 
to WFG (P<0.001). In moderate myopia group, the magn-
itude (P=0.008) and angle of error (P<0.001) were also 
significantly higher in the WFO subgroup. Significantly 
less induction of high order aberrations were found with 
WFG treatments in both low and moderate myopia groups 
(P≤0.006). 
● CONCLUSION: A more efficacious correction of myopic 
astigmatism providing a better visual outcome is achieved 
with WFG LASIK compared to WFO LASIK.
● KEYWORDS: myopia; wavefront-guided LASIK; wavefront-
optimized LASIK; astigmatism
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INTRODUCTION
L aser in situ keratomileusis (LASIK) has demonstrated to be a safe and efficacious technique for the correc-
tion of different levels of ocular astigmatism[1-12]. Two types 
of ablation profiles can be used in LASIK for such purpose: 
wavefront-optimized (WFO) and wavefront-guided (WFG) 
ablation[13]. The aim of WFO algorithms is to minimize the 
induction of spherical aberration (SA) through an approach 
based on refraction and keratometry (aspheric profile)[13]. WFG 
profiles are designed according to the preoperative magnitude 
of low and high order aberrations (HOAs), providing a custom-
ized correction of the optical errors of the eye and maximizing 
the postoperative level of visual quality[13]. WFO algorithms 
are incorporated as a default option in most of currently avail-
able excimer laser platforms. However, WFG ablation profiles 
are calculated based on the ocular aberrometric and corneal 
topographic data obtained by the clinician in the preoperative 
examination. These data must be exported and uploaded to the 
excimer laser computer for their management, being a more 
time-consuming procedure[13].
Some studies have evaluated the potential benefit of WFG 
LASIK treatments over WFO for the correction of astigma-
tism[2,10,12]. Toy et al[2] compared the outcomes of WFO and 
WFG LASIK using the Alcon WaveLight Allegretto Eye-Q 
400-Hz excimer laser platform and found that the WFG profile 
provided more predictable astigmatic corrections in eyes with 
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myopia and astigmatism. Specifically, these authors found that 
the angle of error (AE) of the astigmatic treatment was 80% 
less with the WFG ablation profile compared to the WFO option[2]. 
In contrast, He et al[14] did not find significant differences in 
the level of residual astigmatism among a group of eyes with 
myopic astigmatism treated with WFG LASIK using the Ab-
bott Medical Optics (AMO) Visx CustomVue S4IR excimer 
laser and another group of eyes treated with WFO LASIK 
using the Alcon WaveLight Allegretto Eye-Q 400-Hz excimer 
laser. In another study, Taneri et al[10] only obtained significant 
differences in terms of HOA correction between myopic eyes 
undergoing WFG and WFO LASIK using the Technolas Per-
fect Vision Zyoptix platform. Frings et al[6] found that the most 
limited correction of astigmatism with LASIK was present for 
cylinders of 0.50 D or less as they are commonly overcorrected.
The purpose of the current study was to evaluate and compare 
the clinical outcomes in eyes with low to moderate myopic 
astigmatism as well as the efficacy of the astigmatic correc-
tion evaluated by vector analysis after LASIK using WFG 
(Advanced CustomVue; AMO Inc., Santa Ana, CA, USA) and 
WFO (EX-500 platform, Alcon, Fortworth, Texas, USA) abla-
tion profiles. 
SUBJECTS AND METHODS
Subjects  A prospective, consecutive, comparative, and 
masked clinical trial was performed at Horus Vision Correction 
Centre (HVCC) to evaluate the visual and aberrometric out-
comes of LASIK in 221 eyes with myopic astigmatism. Two 
groups were differentiated according to the magnitude of the 
spherical equivalent (SE) treated: low (from -0.50 to -3.00 D)
(99 eyes) and moderate (from -3.01 to -6.00 D) myopia (122 
eyes) groups. Likewise, each group was subdivided into 
two subgroups according to the ablation profile used for the 
treatment: WFG subgroup including 109 eyes (45 low myopia 
vs 64 moderate myopia) treated using a WFG ablation profile 
(Advanced CustomVue platform, AMO Inc.), and WFO 
subgroup including 112 eyes (54 low myopia vs 58 moderate 
myopia) treated using a WFO profile (EX-500 platform, 
Allegretto Q-500 excimer laser, Alcon). 
Inclusion criteria for the study were patients with myopia 
and/or myopic astigmatism, SE of -6.00 D or below, patients 
requiring spectacle independence and seeking for a laser 
refractive surgery solution, and no previous ocular surgery or 
active ocular disease. Exclusion criteria were myopic SE of 
more than -6.00 D, hyperopic astigmatism, unstable refraction 
for the last 12mo, residual corneal bed thickness <300 mm, 
dry eye, any type of corneal or media opacity, active ocular 
pathology, previous intraocular or corneal surgery, history of 
herpetic keratitis, immunodeficiency, systemic connective 
tissue diseases, insulin-dependent diabetes mellitus, clinical 
or subclinical corneal ectatic disease, history or suspect of 
glaucoma, iris irregularities, and pregnancy or breastfeeding. 
The study received the approval of the HVCC Ethics Com-
mittee. Patients were informed about the surgery and the 
clinical study, and provided informed consent to participate in 
it in accordance with the tenets of the Declaration of Helsinki. 
Examination Protocol  A preoperative ophthalmological 
examination was performed in all patients that included ocular 
and medical history, measurement of uncorrected distance 
visual acuity (UDVA) and corrected distance visual acuity 
(CDVA), manifest and cycloplegic refraction, slit-lamp exa-
mination of the anterior segment, Scheimpflug imaging-
based corneal topography and pachymetry by means of the 
Pentacam HR system (Oculus. Optikgeräte, GmbH Wetzlar, 
Germany) in the WFG subgroups and Placido ring-based 
corneal topography with the WaveLight Topolizer system 
(Alcon) in the WFO subgroups, applanation tonometry (AT 
900, Haag-Streit, Koeniz, Switzerland), contrast sensitivity 
(CS) testing (CVS-1000, Vistech), funduscopy and wavefront 
aberration measurement using the iDesign system (AMO Inc., 
Santa Ana, CA, USA) in both groups. With this aberrometer, 
the magnitude of the root mean square (RMS) for HOAs, 
primary coma and trefoil, and the magnitude of primary SA for 
a pupil aperture of 5 mm were calculated. Soft contact lenses 
and rigid gas permeable contact lenses were removed at least 
one week and three weeks, respectively, prior to this complete 
preoperative examination.
Postoperatively, clinical examinations were performed at 1d, 
1, 3 and 6mo after surgery. These postoperative examinations 
included UDVA and CDVA measurement, manifest refraction, 
biomicroscopic examination, and topographic analysis. At the 
last postoperative visit, CS and aberrometric outcomes were 
also evaluated.
Surgery  All surgeries were performed by the same surgeon 
(Khalifa MA) under topical anesthesia. Before surgery, all eyes 
were prepared by cleansing the periocular zone and two drops 
of topical anesthesia were instilled. Corneal flaps were created 
using the M2 microkeratome (Moria, Antony, France), with 
an intended flap thickness of 110 µm. In the WFG subgroups, 
the STAR S4IR excimer laser was used, with a WFG ablation
calculated according to the iDesign aberrometric measur-
ements. In the WFO subgroups, the Allegretto EX-500 excimer 
laser platform was used. An iris-based torsional registration 
was previously obtained in all cases and used to control 
torsional movements during surgery if necessary. Treatments 
were programmed with a 6-mm optical zone in both groups 
and assuming a refractive target of emmetropia in all cases. 
Standard topical postoperative treatment was administered to 
all patients consisting of a combination of dexamethasone and 
tobramycin four times a day during one week. Also, patients 
were instructed to use an artificial tear solution at least every 
two hours the day after the surgery and at least four times a day 
during one month. After this period, patients were instructed 
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to use artificial tears when needed (foreign body sensation, 
dryness etc.).
Data Analysis  The Alpins vector analysis method was 
used for the analysis of the astigmatic changes occurring 
after surgery[15-16]. The following vectors were determined 
and evaluated: targeted induced astigmatism (TIA) as the 
vector of intended change in cylinder for each treatment, 
surgically induced astigmatism (SIA) as the vector of the real 
change achieved and difference vector (DV) as the additional 
astigmatic change that would enable the initial surgery 
to achieve its intended target. Additionally, the following 
parameters derived from the relationship between these vectors 
were calculated and analyzed at the last postoperative visit. AE: 
the angle described by the vectors of the achieved correction 
(SIA) and the intended correction (TIA). Negative: achieved 
correction is clockwise to its intended axis. Positive: achieved 
correction is counterclockwise to its intended axis. Correction 
index (CI): the ratio of the SIA to the TIA-what the surgery 
actually induced versus what the surgery was meant to induce. 
The CI is preferably 1; it is greater than 1 if an overcorrection 
occurs and less than 1 if there is an undercorrection.
Concerning statistical analyses, all were performed with 
a commercially available software package (SPSS for 
Mac, Version 20.0; IBM Corporation, Armonk, NY, USA). 
Normality of data samples was evaluated by means of the 
Kolmogorov-Smirnov test. When parametric analysis was 
possible, the Student’s t-test for unpaired data was used for 
comparisons between pairs of groups, whereas the Mann-
Whitney test was applied to assess the significance of such 
differences when parametric analysis was not possible. For the 
analysis of differences between preoperative and postoperative 
visits in each group, the Student’s t-test for paired data or the 
Wilcoxon ranked sum test were used depending if the samples 
were normally distributed or not, respectively. For all statistical 
tests, a P-value of less than 0.05 was considered as statistically 
significant. Finally, the efficacy index was calculated as the 
ratio of the postoperative UDVA to the preoperative CDVA, and 
the safety index was calculated as the ratio of the postoperative 
CDVA to the preoperative CDVA[17].
RESULTS
Table 1 summarizes the clinical characteristics of the studied 
groups.
Low Myopia Group Outcomes  Significantly better decimal 
preoperative CDVA (WFG 1.07±0.11 vs WFO 0.99±0.05, 
P=0.041) and postoperative UDVA (WFG 1.07±0.13 vs 
WFO 0.95±0.14, P=0.011) was found in the WFG subgroup 
compared to WFO. A significantly better efficacy index 
was found in the WFG subgroup (WFG 1.00±0.10 vs WFO 
0.96±0.11, P=0.041). A total of 41 (91%) and 47 eyes (87%) 
achieved a postoperative UDVA of 20/20 or better in the WFG 
and WFO subgroups, respectively (Figure 1). More patients 
achieved postoperative UDVA of 20/16 in the WFG subgroup 
compared to the WFO (44.4% vs 13.0%, P=0.001) (Figure 1).
No differences in postoperative decimal CDVA (WFG 
1.12±0.11 vs WFO 1.03±0.10, P=0.107) and safety index 
(WFG 1.05±0.11 vs WFO 1.03±0.12, P=0.275) were found 
among subgroups. Gains of lines of CDVA were observed 
in 15 (33.3%) and 18 eyes (33.3%) in the WFG and WFO 
subgroups, respectively (Figure 2). Losses of lines of CDVA 
were only observed in the WFO subgroup (1 eye, 1.9%) 
(Figure 2).
Manifest SE changed significantly from a mean preoperative 
value of -1.99±0.60 D to a mean postoperative value of 
-0.14±0.18 D (P<0.001) in the WFG subgroup and from 
-2.15±0.46 D to -0.49±0.39 D (P<0.001) in the WFO subgroup 
(Figure 3). No significant differences were observed between 
the SE achieved at 1 and 6mo postoperatively in any subgroup 
(WFG, P=0.322; WFO, P=0.582). No significant differences 
Table 1 Preoperative clinical characteristics of the studied groups
Parameters
Low myopia Moderate myopia
WFG WFO P WFG WFO P
Sphere (D) 0.041 0.042
Mean (SD) -1.90 (0.58) -1.53 (0.74) -4.21 (0.83) -4.02 (0.89)
Range -3.00 to -0.63 -3.00 to -0.47 -5.88 to -2.88 -5.46 to -2.47
Cylinder (D) 0.107 0.107
Mean (SD) -1.20 (0.86) -1.12 (1.32) -1.31 (0.65) -1.47 (1.26)
Range -3.25 to 0.00 -4.50 to 0.00 -2.75 to 0.00 -4.75 to 0.00
SE (D) 0.023 0.098
Mean (SD) -1.99 (0.60) -2.15 (0.46) -4.36 (0.84) -4.67 (0.86)
Range -3.00 to -0.63 -3.00 to -1.38 -6.00 to -3.13 -6.00 to -3.38
Decimal CDVA 0.041 0.104
Mean (SD) 1.07 (0.11) 0.99 (0.05) 1.01 (0.11) 1.00 (0.07)
Range 0.80 to 1.20 0.80 to 1.20 0.90 to 1.20 0.80 to 1.20
CDVA: Corrected distance visual acuity; SD: Standard deviation. 
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among groups were found in preoperative SE (P=0.098), 
but a higher postoperative value was present in the WFO 
subgroup compared to WFG (P=0.002). More patients in the 
WFG subgroup achieved a postoperative SE within ±0.25 D 
(WFG 84.4% vs WFO 66.8%, P=0.015) (Figure 4). Regarding 
manifest cylinder, it was reduced significantly with surgery in 
both subgroups (WFG: from -1.20±0.86 D preoperatively to 
-0.06±0.16 D at 6mo postoperatively, P=0.001; WFO: from
-1.12±1.32 D preoperatively to -0.20±0.34 D at 6mo posto-
peratively, P=0.001). Significant differences between sub-
groups were found in the magnitude of cylinder postoperatively 
(P=0.001) that were not present preoperatively (P=0.107). 
More patients had a 6-month postoperative cylinder of 0.25 D or 
below in the WFG subgroup compared to the WFO subgroup, 
but the difference was not statistically significant (WFG 88.9% 
vs WFO 74.1%, P=0.235) (Figure 5).
No significant changes in CS for any spatial frequency 
evaluated were found at 6mo postoperatively (P≥0.107). The 
change induced with surgery in primary coma (P=0.006) and 
SA (P=0.005) was significantly lower in the WFG subgroup 
compared to the WFO subgroup (Figure 6).
Moderate Myopia Group Outcomes  No statistically signi-
ficant differences among WFG and WFO subgroups were 
found in decimal preoperative CDVA (WFG 1.01±0.11 vs 
WFO 1.00±0.07, P=0.104). In contrast, significantly better 
postoperative UDVA (WFG 1.01±0.11 vs WFO 0.93±0.11, 
P=0.017) and better efficacy index (WFG 1.00±0.10 vs 
WFO 0.93±0.11, P=0.027) was found in the WFG subgroup 
compared to WFO. A total of 59 (92.2%) and 52 eyes (89.7%) 
achieved a postoperative UDVA of 20/20 or better in the 
Figure 1 Distribution of preoperative CDVA and postoperative 
UDVA at 6mo after surgery in the WFG and WFO subgroups  A: 
Low myopia group; B: Moderate myopia group.
Figure 2 Change in CDVA during the follow-up in the WFG and 
WFO subgroups of the low and moderate myopia groups. 
Figure 3 Change in the SE during the follow-up in the WFG and 
WFO subgroups of the low and moderate myopia groups.
Figure 4 Distribution of the 6-month postoperative SE in the 
WFG and WFO subgroups of the low and moderate myopia groups.
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WFG and WFO subgroups, respectively (Figure 1). More 
patients achieved a postoperative UDVA of 20/16 in the WFG 
subgroup compared to the WFO (17.2% vs 3.4%, P=0.001) 
(Figure 1). No significant differences among groups were 
found in postoperative decimal CDVA (WFG 1.08±0.12 vs 
WFO 1.01±0.08, P=0.106) and safety index (WFG 1.07±0.12 
vs WFO 1.01±0.10, P=0.081). Gains of lines of CDVA were 
observed in 18 (27.9%) and 14 eyes (14.1%) in the WFG and 
WFO subgroups, respectively. Losses of lines of CDVA were 
only observed in the WFO subgroup (3 eyes, 5.1%).
Manifest SE changed significantly from a mean preoperative 
value of -4.36±0.84 D to a mean postoperative value of -0.38± 
0.16 D (P<0.001) in the WFG subgroup and from -4.67±0.86 D to 
-0.56±0.31 D (P<0.001) in the WFO subgroup (Figure 3). No 
significant differences were observed between the SE achieved 
at 1 and 6mo postoperatively in any subgroup (WFG, P=0.06; 
WFO, P=0.107). Lower SE was present preoperatively 
(P=0.023) and postoperatively (P=0.001) in the WFG 
subgroup compared to the WFO subgroup. More patients in the 
WFG subgroup achieved a postoperative SE within ±0.25 D 
(WFG 85.9% vs WFO 48.3%, P=0.001) (Figure 4). Regarding 
manifest cylinder, it was reduced significantly with surgery 
in both subgroups (WFG: from -1.31±0.65 D preoperatively 
to -0.09±0.16 D at 6mo postoperatively, P=0.001; WFO: 
from -1.47±1.26 D preoperatively to -0.25±0.30 D at 6mo 
postoperatively, P=0.001). The magnitude of cylinder differed 
significantly among subgroups in the last postoperative visit 
(P=0.003), but not preoperatively (P=0.107). More patients 
had a 6-month postoperative cylinder of 0.25 D or below in the 
WFG subgroup compared to the WFO subgroup (WFG 90.6% 
vs WFO 65.5%, P=0.002) (Figure 5).
Regarding CS, only a significant improvement was found 
in the WFG subgroup for the value obtained for the spatial 
frequency of 18 cycles/degree (P=0.028). The change induced 
with surgery in trefoil (P=0.001) and SAs (P=0.001) was 
significantly lower in the WFG subgroup compared to the 
WFO subgroup (Figure 6).
Vector Analysis of Astigmatic Changes  Table 2 summarizes 
the parameters derived from the vector analysis of ocular 
astigmatic changes at the end of the follow-up in the WFG 
and WFO subgroups of the low and moderate myopia groups. 
In the low myopia group, a significantly larger magnitude 
of the DV was found in the WFO group compared to the 
WFG subgroup (P<0.001). In the moderate myopia group, 
a significantly larger magnitude of DV (P<0.001), ME 
(P=0.008), and AE (P<0.001) was found in the WFO subgroup 
compared to the WFG subgroup. Likewise, in this same group, 
a significantly higher CI was found in the WFG subgroup 
(P=0.001).
DISCUSSION
In the last years, advances in excimer laser keratorefractive 
procedures have been focused on improvements in ablation 
profile algorithms, flying spot profiles, and eye tracking 
systems[18-19]. The introduction of WFO and WFG ablation 
profiles has been an important step forward a maximal level 
of optimization of visual outcomes after laser refractive sur-
gery[19]. Recently, new technical advances have led to a further 
improvement of WFG treatments. The development of high 
resolution aberration sensors, avoiding some of the limitations 
of previous aberrometers, and the development of the iris 
registration technology, allowing the compensation for torsional 
movements during surgery, are two of the main latest advances 
improving the results of WFG laser surgery[5]. According to this 
technological implementation, it is expected that WFG treatments 
provide better clinical outcomes than WFO procedures. There are 
some previous comparative studies evaluating the outcomes of 
WFG and WFO treatments[2,10,14,20-22]. Some of these studies 
found some clinical benefits of WFG over WFO treatments 
whereas others did not[2,10,14,20-22]. The current study was aimed 
at comparing the outcomes of WFG LASIK treatments based 
on measurements obtained with a high resolution aberrometer 
and WFO with cyclotorsional registration in low to moderate 
myopic eyes with astigmatism, which are the most frequent 
cases that commonly undergo laser refractive surgery. To our 
knowledge, this is the first study evaluating and comparing the 
Figure 5 Distribution of the 6-month postoperative cylinder in the 
WFG and WFO subgroups of the low and moderate myopia groups.
Figure 6 Distribution of the postoperative change in HOAs in the 
WFG and WFO subgroups of the low and moderate myopia groups.
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efficacy of the astigmatic correction achieved with both types 
of laser ablation profile using vector analysis.
In our study, better postoperative UDVA and efficacy index 
were found in low and moderate myopic eyes with WFG 
treatments compared to WFO. This was related to a relatively 
more limited predictability of the refractive correction achieved 
with WFO profiles. Indeed, postoperative SE and cylinder was 
significantly higher with WFO treatments compared to WFG 
for both low (-0.14±0.18 D vs -0.49±0.39 D, P=0.002) and 
moderate (-0.38±0.16 D vs -0.56±0.31 D, P=0.001) myopic 
eyes. Likewise, more patients with low (84.4% vs 66.8%, 
P=0.015) and moderate myopia (85.9% vs 48.3%, P=0.001) 
undergoing a WFG procedure achieved a postoperative SE 
within ±0.25 D. This is consistent with the results of other 
comparative studies of WFO and WFG LASIK using other 
excimer laser platforms. He et al[14] found in a comparative 
study of WFO (Alcon Allegretto Wave Eye-Q 400 Hz excimer 
laser) and WFG femtosecond-assisted myopic LASIK (AMO 
Visx CustomVue S4 IR excimer laser combined with the 
previous version of the aberrometer used in our that had 5 
times less resolution) a more myopic postoperative SE in 
those eyes undergoing the WFO treatment (-0.13±0.46 D vs 
-0.41±0.38 D). Sales and Manche[21] compared the clinical 
outcomes of WFO and WFG femtosecond-assisted LASIK 
performed with the Alcon WaveLight Allegretto Eye-Q 
400-Hz excimer laser platform. These authors[21] found that 
the frequency with which the WFG group attained a refractive 
error within ±0.25 D of emmetropia was higher with the WFG 
ablation profile than with the WFO ablation (67.6% vs 41.2%, 
P=0.03). Likewise, they confirmed that postoperative UDVA 
in the WFG group was better than in the WFO group by 
approximately 1 Early Treatment Diabetic Retinopathy Study 
line (-0.17±0.11 vs -0.13±0.12, P=0.05)[21]. Taneri et al[10] 
found using the Technolas Zyoptix excimer laser platform that 
67% of eyes treated with LASIK using a WFG profile and 39% 
of eyes treated with a WFO profile achieved a 20/20 UDVA or 
better. All these previous outcomes and the results of our study 
suggest the presence of a relative limitation with WFO ablation 
profiles in the predictability of the refractive correction that has 
a significant impact on the visual outcome achieved.
In our series, the less predictable correction of the cylinder with 
the WFO ablation compared to WFG seems to be the main 
factor contributing to the more limited predictability of SE 
correction with this type of ablation in both low and moderate 
myopic eyes. Indeed, a significantly higher magnitude of 
postoperative cylinder was found in eyes treated with WFO 
ablation profiles compared to those treated with WFG profiles 
(low myopia: -0.06±0.16 vs -0.20±0.34 D, P=0.001; moderate 
myopia: -0.09±0.16 vs -0.25±0.30 D, P=0.003). Furthermore, 
in our study, the percentage of eyes with a postoperative 
cylinder of 0.25 D or below was higher in WFG subgroups 
compared to WFO subgroups. This difference only reached 
statistical significance in the group of eyes with moderate 
myopia (low myopia: 88.9% vs 74.1%, P=0.235; moderate 
myopia: 90.6% vs 65.5%, P=0.002). 
Table 2 The parameters derived from the vector analysis of ocular astigmatic changes at the end of the follow-up in the analyzed sample 
(Alpins method)
Parameters
Low myopia Moderate myopia
WFG WFO P WFG WFO P
TIA (D) 0.166 0.822
Mean (SD) 1.36 (0.85) 1.12 (1.35) 1.39 (0.62) 1.64 (1.26)
Median (range) 1.50 (0.25 to 3.25) 0.51 (0.05 to 4.57) 1.50 (0.25 to 2.75) 1.37 (0.44 to 4.91)
SIA (D) 0.053 0.699
Mean (SD) 1.32 (0.81) 0.95 (1.07) 1.32 (0.53) 1.41 (1.05)
Median (range) 1.26 (0.25 to 3.25) 0.46 (0.03 to 3.68) 1.25 (0.25 to 2.50) 1.16 (0.30 to 4.15)
DV (D) <0.001 <0.001
Mean (SD) 0.08 (0.18) 0.47 (0.41) 0.10 (0.17) 0.53 (0.32)
Median (range) 0.00 (0.00 to 0.50) 0.27 (0.08 to 1.69) 0.00 (0.00 to 0.50) 0.52 (0.14 to 1.52)
ME 0.902 0.008
Mean (SD) 0.05 (0.16) 0.18 (0.45) 0.08 (0.16) 0.23 (0.40)
Median (range) 0.00 (-0.32 to 0.50) 0.06 (-0.39 to 1.68) 0.00 (-0.24 to 0.50) 0.21 (-0.59 to 1.50)
CI 0.617 0.001
Mean (SD) 0.99 (0.13) 1.30 (1.22) 0.97 (0.10) 0.88 (0.26)
Median (range) 1.00 (0.67 to 1.64) 0.77 (0.36 to 6.56) 1.00 (0.74 to 1.48) 0.81 (0.52 to 1.49)
AE (º) 0.541 <0.001
Mean (SD) 0.45 (3.18) -2.81 (20.95) -0.04 (0.87) -1.15 (12.36)
Median (range) 0.00 (-4.71 to 17.50) 0.00 (-59.04 to 58.35) 0.00 (-3.92 to 3.80) -0.56 (-27.88 to 44.97)
TIA: Targeted intended astigmatism; SIA: Surgically induced astigmatism; DV: Difference vector; ME: Magnitude of error; AE: Angle of 
error; CI: Correction index; SD: Standard deviation. Ocular astigmatic changes in the analyzed sample. 
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As the astigmatism is a vector parameter, not only changes in 
its magnitude must be analyzed, but also changes in its axis. 
For this reason, a vector analysis was performed considering 
both astigmatic magnitude and axis changes. According to 
this analysis, the difference between the intended and SIA, 
which is the DV, is related to the more limited predictability 
of cylinder correction with WFO ablation patterns. Higher 
levels of DV were found in WFO subgroups compared to 
WFG subgroups for both low and moderate myopia groups. 
This finding suggests that the use of wavefront aberration 
data allows a more precise planning of the optimal cylinder 
magnitude and axis to correct with the laser ablation. The high 
resolution aberrometer used for planning WFG treatments has 
been shown to provide reliable measurements of astigmatism 
that completely agree with that corresponding to manifest 
refraction[23]. Besides the difference in DV among WFG and 
WFO subgroups, ME and AE were also significantly higher 
in the WFO subgroup of the moderate myopia group. This is 
consistent with the results of Toy et al[2] who found that the 
AE was 80% less in eyes treated with WFG profiles using 
the Alcon WaveLight Allegretto Eye-Q 400-Hz excimer 
laser platform compared to those treated with WFO profiles 
(1.92°±0.67º vs 9.66°±3.7º, P=0.04). This finding suggests 
a potential level of misalignment of the cylinder correction 
leading to some level of astigmatic undercorrection when 
the treatment is applied using a WFO profile instead of a 
WFG laser ablation. It should be considered that the potential 
interaction among HOAs that may affect or interfere with an 
effective correction of astigmatism is taken into account when 
a WFG ablation profile is calculated[24]. This contributes to the 
more optimized outcome in terms of astigmatic correction that 
is observed after WFG LASIK compared to WFO LASIK.
Besides visual and refractive outcomes, ocular aberrometric 
changes were evaluated as well in our series. Higher post-
operative levels of HOAs were found in WFG subgroups 
compared to WFO subgroups in both low and moderate 
myopia groups, which is consistent with the results of pre-
vious studies comparing WFO and WFG LASIK[10,21-22,25-26]. 
Specifically, significantly lower induction of SA was found 
after WFG LASIK in both low and moderate myopia groups 
as well as lower induction of trefoil, but only in eyes with 
moderate myopia. Similarly, more induction of SA with 
WFO profiles was found by Taneri et al[10] in a comparative 
study of WFO and WFG LASIK using the Technolas Zyoptix 
platform. Likewise, Sales and Manche[21] found in another 
comparative study that myopic eyes undergoing WFG 
LASIK had less postoperative trefoil compared with those 
undergoing WFO LASIK. In contrast, He et al[14] did not find 
significant differences in the postoperative levels of residual 
astigmatism (P=0.798) or HOAs (P=0.869) after WFO and 
WFG femtosecond-assisted LASIK. These discrepancies 
among studies may be attributed to several factors including 
differences in study populations, clinical procedures followed 
and excimer laser platforms used. For this reason, a significant 
variability in terms of CS outcomes can be found in different 
previous studies comparing the visual performance after 
WFO and WFG LASIK[2,10,14,20-22]. In our study, no significant 
changes in CS were found in low myopic eyes with WFG or 
WFO treatments, but a significant improvement in CS was 
observed in the WFG subgroup of the moderate myopia group 
for the spatial frequency of 18 cycles/degree. 
Finally, no significant differences in terms of safety were 
found between WFO and WFG subgroups in both low and 
moderate myopia groups of our sample, with no significant 
differences in postoperative CDVA and safety index. Losses 
of lines of CDVA were only reported in a minimal number of 
patients operated on with WFO ablation profiles. Therefore, 
the difference in the control of HOAs with WFG and WFO 
ablation profiles detected in the two groups of our sample did 
not have a significant impact on the maximum level of visual 
acuity achievable by the patient. This may be due to the low 
level of aberrometric induction with both types of ablation 
profiles. Possibly, in eyes with high myopia, this impact is 
more significant as the difference in the level of induction of 
HOAs with WFG and WFO profiles is considerably higher. 
Al-Zeraid and Osuagwu[27] found higher level of induction of 
HOAs in eyes with high myopic astigmatism undergoing WFG 
LASIK compared to those with moderate myopic astigmatism. 
Other authors comparing WFG and WFO LASIK have reported 
significant differences in CDVA between ablation profiles, 
such as He et al[14].
In conclusion, WFG LASIK provides a more efficacious 
correction of astigmatism in eyes with low to moderate myopic 
astigmatism than WFO LASIK, with better control of HOAs 
leading to a more optimized visual outcome. The less induction 
of HOAs and more predictability of cylinder correction may be 
attributed to variable factors such as better axial and torsional 
registration with centroid shift, high resolution detection of 
the aberrations with more detailed ablation profile, and more 
delivery of energy to the midperiphery of the cornea. Future 
comparative studies in eyes with high myopic astigmatism 
should be conducted in order to confirm if the benefit of WFG 
over WFO treatments is still higher.
ACKNOWLEDGEMENTS 
Foundation: Partially supported by a grant from Abbott 
Medical Optics.
Conflicts of Interest: Khalifa MA, None; Alsahn MF, None; 
Shaheen MS, None; Pinero DP, None.
REFERENCES
1 Schallhorn SC, Venter JA, Hannan SJ, Hettinger KA. Clinical outcomes 
of wavefront-guided laser in situ keratomileusis to treat moderate-to-high 
astigmatism. Clin Ophthalmol  2015;9:1291-1298. 
292
2 Toy BC, Yu C, Manche EE. Vector analysis of 1-year astigmatic 
outcomes from a prospective, randomized, fellow eye comparison of 
wavefront-guided and wavefront-optimized LASIK in myopes. J Refract 
Surg  2015;31(5):322-327. 
3 Ziaei M, Mearza AA, Allamby D. Wavefront-optimized laser in situ 
keratomileusis with the Allegretto Wave Eye-Q excimer laser and the 
FEMTO LDV Crystal Line femtosecond laser: 6 month visual and 
refractive results. Cont Lens Anterior Eye  2015;38(4):245-249. 
4 Bohac M, Biscevic A, Koncarevic M, Anticic M, Gabric N, Patel S. 
Comparison of Wavelight Allegretto Eye-Q and Schwind Amaris 750S 
excimer laser in treatment of high astigmatism. Graefes Arch Clin Exp 
Ophthalmol  2014;252(10):1679-1686. 
5 Schallhorn S, Brown M, Venter J, Teenan D, Hettinger K, Yamamoto H. 
Early clinical outcomes of wavefront-guided myopic LASIK treatments 
using a new-generation hartmann-shack aberrometer. J Refract Surg 
2014;30(1):14-21. 
6 Frings A, Katz T, Richard G, Druchkiv V, Linke SJ. Efficacy and 
predictability of laser in situ keratomileusis for low astigmatism of 0.75 
diopter or less. J Cataract Refract Surg  2013;39(3):366-377. 
7 Alio JL, Pachkoria K, El Aswad A, Plaza-Puche AB. Laser-assisted 
in situ keratomileusis in high mixed astigmatism with optimized, fast-
repetition and cyclotorsion control excimer laser. Am J Ophthalmol 
2013;155(5):829-836. 
8 Alió JL, Plaza-Puche AB, Martinez LM, Torky M, Brenner LF. Laser 
in situ keratomileusis using optimized aspheric profiles and cyclotorsion 
control to treat compound myopic astigmatism with high cylinder. J 
Cataract Refract Surg  2013;39(1):28-35. 
9 Fares U, Otri AM, Al-Aqaba MA, Faraj L, Dua HS. Wavefront-
optimized excimer laser in situ keratomileusis for myopia and myopic 
astigmatism: refractive outcomes and corneal densitometry. J Cataract 
Refract Surg  2012;38(12):2131-2138. 
10 Taneri S, Oehler S, MacRae SM. Aspheric wavefront-guided versus 
wavefront-guided LASIK for myopic astigmatism with the Technolas 
217z100 excimer laser. Graefes Arch Clin Exp Ophthalmol  2013;251 
(2):609-616. 
11 Huang H, Yang J, Bao H, Chen S, Xia B, Zou J. Retrospective analysis 
of changes in the anterior corneal surface after Q value guided LASIK 
and LASEK in high myopic astigmatism for 3 years. BMC Ophthalmol 
2012;12:15. 
12 Labiris G, Gatzioufas Z, Giarmoukakis A, Sideroudi H, Kozobolis 
V. Evaluation of the efficacy of the Allegretto Wave and the Wavefront-
optimized ablation profile in non-anterior astigmatisms. Acta Ophthalmol 
2012;90(6):e442-446. 
13 Feng Y, Yu J, Wang Q. Meta-analysis of wavefront-guided vs wavefront-
optimized LASIK for myopia. Optom Vis Sci  2011;88(12):1463-1469.
14 He L, Liu A, Manche EE. Wavefront-guided versus wavefront-
optimized laser in situ keratomileusis for patients with myopia: a prospective 
randomized contralateral eye study. Am J Ophthalmol  2014;157(6):1170-1178.
15 Alpins NA. New method of targeting vectors to treat astigmatism. J 
Cataract Refract Surg  1997;23(1):65-75.
16 Alpins N. Astigmatism analysis by the Alpins method. J Cataract 
Refract Surg  2001;27(1):31-49.
17 Waring GO 3rd. Standard graphs for reporting refractive surgery. J 
Refract Surg  2000;16(4):459-466.
18 Arba Mosquera S, Verma S. Effects of torsional movements in 
refractive procedures. J Cataract Refract Surg  2015;41(8):1752-1766. 
19 Myrowitz EH, Chuck RS. A comparison of wavefront-optimized and 
wavefront-guided ablations. Curr Opin Ophthalmol  2009;20(4):247-250.
20 He L, Manche EE. Contralateral eye-to-eye comparison of wavefront-
guided and wavefront-optimized photorefractive keratectomy: a 
randomized clinical trial. JAMA Ophthalmol  2015;133(1):51-59.
21 Sales CS, Manche EE. One-year outcomes from a prospective, 
randomized, eye-to-eye comparison of wavefront-guided and wavefront-
optimized LASIK in myopes. Ophthalmology  2013;120(12):2396-2402. 
22 Moshirfar M, Betts BS, Churgin DS, Hsu M, Neuffer M, Sikder S, 
Church D, Mifflin MD. A prospective, randomized, fellow eye comparison 
of WaveLight® Allegretto Wave® Eye-Q versus VISX CustomVue™ 
STAR S4 IR™ in laser in situ keratomileusis (LASIK): analysis of visual 
outcomes and higher order aberrations. Clin Ophthalmol  2011;5:1339-1347. 
23 Sáles CS, Manche EE. Comparison of ocular aberrations measured 
by a Fourier-based Hartmann-Shack and Zernike-based Tscherning 
aberrometer before and after laser in situ keratomileusis. J Cataract Refract 
Surg  2015;41(9):1820-1825. 
24 de Gracia P, Dorronsoro C, Gambra E, Marin G, Hernández M, Marcos 
S. Combining coma with astigmatism can improve retinal image over 
astigmatism alone. Vision Res  2010;50(19):2008-2014. 
25 El Awady HE, Ghanem AA, Saleh SM. Wavefront-optimized ablation 
versus topography-guided customized ablation in myopic LASIK: com-
parative study of higher order aberrations. Ophthalmic Surg Lasers Imaging 
2011;42(4):314-320.
26 Padmanabhan P, Mrochen M, Basuthkar S, Viswanathan D, Joseph R. 
Wavefront-guided versus wavefront-optimized laser in situ keratomileusis: 
contralateral comparative study. J Cataract Refract Surg  2008;34(3): 
389-397.
27 Al-Zeraid FM, Osuagwu UL. Induced higher-order aberrations after 
laser in situ keratomileusis (LASIK) performed with wavefront-guided 
IntraLase femtosecond laser in moderate to high astigmatism. BMC 
Ophthalmol  2016;16:29. 
Efficacy of wavefront-guided and optimized LASIK
